![[(4R,5S)-4,5-Bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]methanone structure, CAS 939981-39-2](/structures/210000/196541_1_939981_39_2.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 939981-39-2 |
| Catalog No. | 2A-1194873 |
| Chinese Name | [(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基][4-[3-(甲磺酰基)丙基]-1-哌嗪基]甲酮 |
| Synonyms | CS-0330; RG7112; RG-7112 |
| Molecular Formula | C38H48Cl2N4O4S |
| Molecular Weight | 727.78 |
| Purity | ≥98 (HPLC) |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 790.4±70.0 °C at 760 mmHg |
| Appearance | powder |
| Storage Condition | -20℃ |
| Application | RG7112 is the first clinically available orally available MDM-2/p53 inhibitor with a Kd value of 11 nM. |
| PubChem ID | 136952608 |
| MDL Number | MFCD29905459 |
| SMILES | [S](=O)(=O)(CCCN1CCN(CC1)C(=O)N2[C@]([C@](N=C2c5c(cc(cc5)C(C)(C)C)OCC)(C)c4ccc(cc4)Cl)(C)c3ccc(cc3)Cl)C |
| InChI | 1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1 |
| InChI Key | QBGKPEROWUKSBK-QPPIDDCLSA-N |
| NACRES Code | NA.21 |
| MSDS | msds/196541_1_939981_39_2.pdf |
| Transport Info | Product name: RG7112 |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA